Physician profile
Bindu Singhal
NPI 1073546057
$1,241.49
in general payments reported to CMS, 2019-2025
11 companies · $76.11 in 2025
The $76.11 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $126 · 2022: $242 · 2023: $193 · 2025: $76.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $193.21 | 2019-2023 | Lynparza |
| Portola Pharmaceuticals, LLC | $126.35 | 2020 | |
| Csl Behring | $124.77 | 2022 | |
| Horizon Therapeutics Plc | $124.48 | 2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $118.09 | 2019 | |
| Boston Scientific Corporation | $117.33 | 2022 | |
| Pacira Therapeutics, INC. | $117.16 | 2019 | |
| Covidien Lp | $111.02 | 2019 | |
| Lilly USA, LLC | $85.97 | 2019 | |
| Genzyme Corporation | $76.11 | 2025 | |
| Coloplast Corp | $47.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindu Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.